Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_assertion type Assertion NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_head.
- NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_assertion description "[We exposed the androgen-independent/androgen receptor (AR)-negative prostate cancer cell line DU145 to NGF to study whether this neurotrophin could revert DU145 cells to a less malignant phenotype.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_provenance.
- NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_assertion evidence source_evidence_literature NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_provenance.
- NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_assertion SIO_000772 12213679 NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_provenance.
- NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_assertion wasDerivedFrom befree-2016 NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_provenance.
- NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_assertion wasGeneratedBy ECO_0000203 NP366919.RAK8Wlz-RkF38-zAaUU5oynPfPgmLJKQL_RVex1fJPx7o130_provenance.